Background: One of the major drawbacks of current depression pharmacotherapy is the delay in symptom improvement, aside from the untoward side effects and lack of efficacy against refractory depression. This work therefore investigated a possible rapid-onset and sustained antidepressant effect of Mallotus oppositifolius. Methods: Onset of the antidepressant effect of hydroalcoholic extract from the leaves of M. oppositifolius was investigated using the open space swim test, a chronic depression model. The possible effects of the extract on cognitive dysfunction measured in the Morris water maze and weight gain were also investigated. Results: M. oppositifolius extract, after the first day of treatment, reversed the state of immobility in mice. This effect was sustained even after drug treatment was halted and the antidepressant effect verified in the tail suspension test. The extract also increased the total distance travelled by the mice and reversed the cognitive impairment induced by the depressed state but had no effect on weight variation. Conclusions: M. oppositifolius exhibits a rapid-onset and sustained antidepressant effect in mice.
Introduction
Significant research work has been carried out on major depressive disorder (depression) and great progress has been made for more than six decades now. The introduction of the selective serotonin reuptake inhibitors (SSRIs), e.g. fluoxetine, has revolutionized depression pharmacotherapy owing to their improved side effect profile when compared with the older drug classes (the tricyclic antidepressants and monoamine oxidase inhibitors) [1] . This milestone has however failed to address the delay in symptom improvement as patients have to take the SSRIs for many weeks before clinical efficacy is observed [2] . Studies indicate that there is a positive correlation between the delay in symptom improvement and suicidality. Furthermore, about 30%-40% of patients have pharmacoresistant depression which does not respond to the SSRIs [2] . Drug combination has failed to address the current enigma though the results are better than monotherapy [3] . It is evident that more intensive research is needed to address the conundrum.
Earlier we demonstrated in our laboratory that hydroethanolic leaf extract of Mallotus oppositifolius demonstrated an antidepressant effect in acute models [4] in the forced swimming (FST) and tail suspension tests (TST). In this study we reported that the observed antidepressant effect was mediated via a complex interplay of enhancement of serotoninergic and opioidergic neurotransmission, and inhibition of the glycine/N-methyl-D-aspartate (NMDA) receptor complex. Preclinical studies suggest the existence of rapid-onset antidepressant compounds that act through inhibition of the glycine/NMDA receptor complex. Could M. oppositifolius possess a rapid-onset antidepressant effect? Though predictive of antidepressant activity, the FST and TST are unlike human depression [5, 6] . Thus investigations were carried out to ascertain whether the extract from M. oppositifolius will exhibit an antidepressant effect with chronic administration in the open space swim test, a chronic depression model. The open space swim test was chosen because it has closer resemblance to human depression while maintaining its predictive and construct validity [7, 8] .
Depression itself and some antidepressants induce significant weight changes (loss or gain) and alter cognitive function among others [9] [10] [11] [12] . These are challenges in the pharmacological management of depression. Ketamine and other drugs that antagonize the NMDA receptor negatively affect cognitive function. However, drugs that interact as antagonist or partial agonist at the glycine/ NMDA receptor complex lack these negative effects [13] . Since the extract antagonized the glycine/NMDA receptor complex, the effect of the extract on cognitive function using the Morris water maze was also assessed. Finally, the impact of the extract on weight changes in the depressed rodents was examined.
Materials and methods
Leaves of the plant M. oppositifolius were collected from the wild around the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana (6°41′6.4″N, 1°33′42.8″W), and authenticated at the Department of Herbal Medicine of the Faculty of Pharmacy and Pharmaceutical Sciences, KNUST, Kumasi, where a voucher specimen (KNUST/FP/035/09) was deposited. After airdrying for 7 days, the leaves were pulverized with a hammermill and the powder was extracted by cold maceration using 70% (v/v) ethanol in water over a period of 72 h. The resulting extract was concentrated at moderate temperature (60 °C) and pressure to a syrupy mass on a rotary evaporator. The syrupy mass was then dried to a dark brown semisolid mass using water bath and kept in a desiccator till it was ready to be used. The final yield was 19.5% (w/w). This is subsequently referred to as M. oppositifolius extract (MOE) or extract.
Animals
Male Inprinting control region (ICR) mice were obtained from and housed at the animal facility of the Department of Pharmacology, KNUST, Kumasi, Ghana. The animals were housed in groups of 10 in stainless steel cages (34 × 47 × 18 cm 3 ) with soft wood shavings as bedding, fed with normal commercial pellet diet (GAFCO, Tema, Ghana), given water ad libitum, and maintained under laboratory conditions. All animals used in these studies were treated in accordance with the Guide for the Care and Use of Laboratory Animals (NRC, 1996) and experiments were approved by the College Ethics Committee.
Chemicals
Fluoxetine hydrochloride (Prozac) was from Eli Lilly and Co. (Basingstoke, England). Imipramine hydrochloride (Tofranil) from Mallinckrodt Pharmaceuticals (Ireland).
Open space swim test
The method described in [8] was used with some slight modifications. Swimming was carried out in rat tub cages (24 × 30 × 45 cm 3 , w × h × l) filled with 13 cm high tepid tap water (32-34 °C). Mice were swum individually for 15 min/day for 4 consecutive days in order to induce a depressive state characterized by the decrease in both mobility and distance travelled by the mice. Drug treatment with fluoxetine (3-30 mg/kg; n = 10; i.p.), imipramine (3-30 mg/ kg; n = 10; i.p.) or extract (10-100 mg/kg; n = 10; p.o.) started from day 5 to day 18 once daily. All swim sessions were videotaped from above on days 5, 7, 10, 14 and 18. No special procedures were used to dry or warm the animals as they rapidly dried themselves with no observable episodes of shivering. The distance swum was rated as the number of quadrants of the tub entered and duration of immobility from the total time the animal was observed to float, which is defined as drifting with the tail fully extended and no motion observed in the tail or limbs.
Tail suspension test
The tail suspension test was performed 24 h after the last treatment in the open space swim test to ascertain if the behavioural effect will be sustained. The method used has been previously described in [14] .
Spatial learning and memory task -Morris water maze
The effects of the induced depressive behaviour on spatial learning and memory were evaluated with the Morris water maze task [15] in an 85-cm-diameter pool (24±1 °C). The maze was divided into four quadrants. Naïve control mice (mice not exposed to the open space swim test) were allowed to swim for 1 min in the pool without a hidden platform, the same day when the other groups were on their third day of depressive behaviour induction. Twenty-four hours later, all mice were swum in two sessions a day for 4 days to find a hidden platform (5 cm diameter). The platform was centred in one of the quadrants and submerged about 2 cm below the water surface which was kept opaque. The wall of the experimental room had distinctive visual cues to enable mice navigate their way. At the start of all trials, mice were placed in the water facing the maze wall, using different starting positions, and allowed to swim until they found the platform where they remained for 20 s. A mouse that failed to find the platform within 1 min was guided there, with the maximum latency of 60 s scored. The swimming activity was observed for latency to find the platform. Mice with impaired cognitive function will take a longer time to find the platform.
Weight variation
Weights of mice were taken with a sensitive electronic balance when chronic depression was being induced and every 3 days during the treatment period. The change in weight was calculated to ascertain drug-induced changes in the weight of the mice.
Results

The open space swim test
Extract showed a significant antidepressant effect in mice exposed to the open space swim test. From the time course curve, a decrease in immobility by extract was observed after the first day of treatment and this was sustained till the fourteenth day of treatment (F 3,216 = 34.48, p < 0.0001) ( Figure 1A) . The graph showing the area under the curve (AUC) for the extract-treated group also showed a dosedependent decrease in immobility period (F 3,36 = 369.8, p < 0.0001) ( Figure 1B ). In contrast, MOE increased the distance travelled by mice (F 3,216 = 4.05, p < 0.0001) (Figure 2A) . One-way ANOVA showed that the distance travelled was significantly increased in extract-treated groups at all dose levels (F 3,36 = 28.42, p < 0.0001) ( Figure 2B ). Both imipramine ( Figure 1C and D) and fluoxetine ( Figure 1E and F), the standard antidepressant used, showed a decrease in immobility time after day 7 of treatment but a similar effect as extract with regard to the distance travelled ( Figure 2C-F) .
Effect of extract on learning and memoryMorris water maze
Extract improved spatial memory and learning task in mice exposed to the open space swim test. From the time course curve, the extract significantly reduced latency for the mice to find the hidden platform from the third day (F 4,180 = 23.41, p < 0.0001) ( Figure 3A) . Two-way ANOVA revealed that treatment had an effect on the behavioural response (F 4,45 = 3.37, p < 0.0169). The graph showing the AUC revealed that the extract dose dependently reduced latency to find the hidden platform (F 4,45 = 3.139, p < 0.0233) ( Figure 3B ). Spatial memory and learning was improved in naïve mice (mice that were not exposed to the open space swim test). Similar results as the extract were obtained for fluoxetine. In contrast, imipramine did not show any memory improvement (see Figure 3F ).
Investigating a sustained antidepressant effect of the extract
The extract maintained a significant antidepressant effect 24 h after treatment day 14 in the TST. It demonstrated a dose-dependent decrease in both the absolute immobility period and the percentage immobility period at all dose levels. Similar results were obtained for fluoxetine and imipramine (see Figure 4) .
Effect of extract on weight changes
Extract did not have any significant effect on the weight of mice during induction of chronic depression and after the 2-week period of treatment ( Figure 5A and B) . Imipramine significantly reduced the weight of the mice at all dose levels whilst the lowest dose of fluoxetine significantly reduced the weight of the mice after the 2-week period ( Figure 5C-F) .
Discussion
This study has demonstrated that M. oppositifolius, a Ghanaian herb, has a rapid-onset and sustained antidepressant effect devoid of cognitive dysfunction and weight gain in the open space swim test.
Depressed patients often have suicidal tendencies and the delay in improvement of symptomatology as observed with most antidepressants may increase mortality if medications with a faster onset and sustained effect are not sought [16] . According to Stone and Lin [8] , depressed mice in the open space swim test model respond only to chronic treatment with the current antidepressants ( ≥ 2 weeks) and not to acute or subacute treatment. While this delay in the onset of action was observed in imipramine-and fluoxetine-treated mice, it was not so in the extract-treated groups. The antidepressant effect of the extract with regard to immobility period, which is deemed the more consistent index in mice [6, 8] , began on the first day of treatment. A complex array of neuropharmacological changes, such as desensitization of 5-HT autoreceptors (5HT 1A and 5HT 1B/D ) and transporters, downregulation of neurotransmitter receptors, changes in signal transduction, mobilization of neurotrophins, and increases in hippocampal neurogenesis that emerge after chronic treatment with antidepressants, may be involved in their clinical efficacy and the interval taken for these processes to occur may contribute to the time lag in their clinical onset of action [17] [18] [19] [20] . For a faster onset of action, drugs may act as antagonist at presynaptic 5-HT 1A receptors or bypass the inertia of the autoinhibitory mechanisms of the serotonin receptors [21, 22] . The inhibitory effect of the 5-HT 1A autoreceptors is one of the reasons for the delay in the onset of action of antidepressants affecting 5-HT systems [23] . Moreover, drugs that activate the 5HT 4 receptors demonstrated a faster onset of action in vitro and in animal models that were known to respond to chronic treatment only [24] . Additionally, 1-aminocyclopropanecarboxylic acid, a partial agonist on the glycine/ NMDA site, produced a faster onset of action than biogenic amine-based agents [13, 25] . Our laboratory demonstrated that M. oppositifolius produces its antidepressant effect by enhancing serotoninergic neurotransmission and antagonizing the glycine/NMDA system [4] . It is thus plausible that the extract interacts with these systems to produce its rapid-onset antidepressant effect in the open space swim test. It is interesting to note that the antidepressant effect of the extract was sustained throughout the treatment period. In fact, a day after the fourteenth day of treatment, the behavioural effect of the extract was still maintained in the tail suspension test, one of the widely used and validated models of antidepressant. Further work is being carried out to fully appreciate the mechanism by which the extract produces it rapid-onset and sustained antidepressant effect and also to isolate the bioactive compound responsible for the observed phenomenon. Depression in humans has dramatic impact on cognition, including memory and learning [26, 27] . Induced depressive behaviour in rodents has a lasting impact (at least for days) on learning and memory and this impairment is sensitive to antidepressant treatment [15] . Findings in this study support this fact. The time taken to locate the hidden platform in the Morris water maze was higher (indicative of cognitive impairment) in untreated depressed mice but reduced with treatment. In extracttreated mice, naïve unswum mice or fluoxetine-treated mice latency to find the hidden platform decreased on daily basis but not in the depressed untreated mice or imipramine-treated mice. The role of the serotoninergic and the glycine/NMDA systems in memory has been well documented [28, 29] . Converging evidence indicates that activation of 5HT 2A/2C and 5HT 4 receptor agonists prevents memory impairment and facilitates learning, while their antagonists have an opposite effect [28, 30] . It is therefore not startling that MOE should improve memory since it potentiated the 5-hydroxytryptophan-induced head twitch response, which is mediated via 5HT 2A receptor activation [31, 32] . Though some studies suggest that NMDA antagonists impair memory [33] , there have also been reports about their beneficial effects on memory and learning [34, 35] . For instance, memantine, an NMDA receptor antagonist, has been shown to be of value in conditions such as Alzheimer's, dementia and Parkinson's diseases where memory is impaired [35] . It is possible that the inhibitory effect of the extract against the glycine/NMDA receptor complex or pathway also contributed to the memory improvement in the Morris water maze test.
Significant weight changes (increase or decrease) are found among many depressed patients [36] . This could be attributed to the condition and/or antidepressant-induced adverse effects [10, 37] . Serotonin has a significant influence on appetite, and therefore considering the fact that MOE interacts with serotoninergic pathways, the effect of extract on weight variation was investigated [38] . Results indicated that the extract did not affect the weight of the mice significantly although slight weight reductions were observed at all dose levels.
Although this work was not conducted in human species, the evidence gathered gives us hope that the fight against depression can be won.
Conclusions
The current study reports for the first time the presence of a herbal plant, M. oppositifolius, with a rapid-onset * * * * * * * * * * * * * * * * * * * * * * * * * * * and sustained antidepressant effect, devoid of memory impairment and weight changes.
